Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06461351

Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

Sponsor: Juventas Cell Therapy Ltd.

View on ClinicalTrials.gov

Summary

This clinical trial adopts an observational research method to conduct annual follow-up and monitoring of patients receiving treatment with Inaticabtagene Autoleucel Injection after its commercialization, in order to evaluate the delayed adverse events of Inaticabtagene Autoleucel Injection.

Official title: A Long Term Follow-up Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2024-03-30

Completion Date

2040-03-30

Last Updated

2025-08-07

Healthy Volunteers

No

Conditions

Interventions

OTHER

Inaticabtagene autoleucel Injection

Inaticabtagene autoleucel Injection

Locations (1)

Institute of Hematology & Blood Diseases Hospital

Tianjin, Tianjin Municipality, China